11
Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:March 17, 2021Completed
Factor VIII: 838 Clinical Trials, Page 2 of 84
Hide Studies Not Open or Pending
12
Improved Factor VIII Inhibitor Evaluation
Condition(s):Hemophilia; Hemophilia ALast Updated:February 25, 2021Withdrawn
13
PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A
Condition(s):Hemophilia ALast Updated:April 4, 2017Completed
14
Hemophilia Adult Prophylaxis Study: Factor VIII in Severe Hemophilia A
Condition(s):Severe Hemophilia ALast Updated:October 7, 2016Terminated
15
Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT®
Condition(s):Hemophilia A; Hemophilia; Factor VIII DeficiencyLast Updated:March 17, 2021Recruiting
16
Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A
Condition(s):Hemophilia ALast Updated:April 15, 2021Recruiting
17
ADYNOVATE Drug Use-Results Survey
Condition(s):Hemophilia ALast Updated:March 3, 2022Recruiting
18
Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies
Condition(s):Acquired Hemophilia ALast Updated:May 5, 2021No longer available
19
An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.
Condition(s):Haemophilia ALast Updated:February 15, 2018Completed
20
A Study of TAK-660 in Surgical Procedures for People With Hemophilia A.
Condition(s):Hemophilia ALast Updated:October 6, 2021Recruiting